ArticleGenes & diseases2024

Targeting TMEM16A/ANO1 inhibits the progression of BRAF mutant (V600E) melanoma through the MEK/ERK and AKT signaling pathways.

Meiyun Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.